Related Experiment Videos
Gastroduodenal diseases of childhood
Gayle Horvitz1, Benjamin D Gold
1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Insights
Pediatric gastric and duodenal diseases are evolving, with rising H. pylori resistance and new eosinophilic conditions. Early diagnosis and novel treatments improve outcomes for children with these gastrointestinal disorders.
Area of Science:
- Pediatric Gastroenterology
- Gastrointestinal Diseases
- Child Health
Background:
- Helicobacter pylori infections are primarily acquired in childhood, despite declining prevalence.
- Increasing resistance to standard therapies and decreasing eradication rates for H. pylori pose clinical challenges.
- Eosinophilic gastrointestinal diseases are increasingly recognized in children, with ongoing research into their epidemiology and treatment.
Purpose of the Study:
- To review recent advancements in the etiology and management of pediatric gastric and duodenal diseases.
- To highlight emerging trends in the diagnosis and treatment of common childhood gastrointestinal conditions.
Main Methods:
- Literature review of new developments in pediatric gastroduodenal diseases.
- Analysis of current research on H. pylori, eosinophilic disorders, and celiac disease.
- Synthesis of findings on diagnostic tools and therapeutic strategies.
Main Results:
- Most new H. pylori infections occur in childhood, with growing resistance to standard triple therapy.
- Biologic therapies are under development for eosinophilic gastrointestinal diseases.
- Dietary factors and timing of solid food introduction may influence celiac disease development in infants.
Conclusions:
- Novel diagnostic and therapeutic approaches are significantly improving the care of pediatric gastric and duodenal diseases.
- Less invasive, accurate diagnostic tools are becoming more validated.
- Early diagnosis and intervention can alter the natural history and enhance the quality of life for children with gastroduodenal disorders.
Purpose Of Review:
This paper will review new developments in the etiology and management of gastric and duodenal diseases affecting children.
Recent Findings:
Despite dropping prevalence rates in developed nations, most new Helicobacter pylori infections are primarily acquired during childhood. Resistance to standard triple therapy and falling eradication rates are increasing problems for clinicians, necessitating the study of alternative treatment strategies. Eosinophilic diseases of the gastrointestinal tract are being increasingly recognized. Although population-based epidemiology and the natural history of eosinophilic diseases are not yet fully characterized, biologic therapies are in development for the treatment of these chronic, often refractory, conditions. A recent US National Institutes of Health celiac disease consensus conference suggested that infants' diet constituents and timing of solid food introduction are potential environmental influences in the development of celiac disease.
Summary:
New methods of diagnosis and treatment are greatly impacting care of pediatric patients with gastric and duodenal diseases. Less invasive but highly accurate tools for diagnosis are becoming better validated. Early diagnosis and effective intervention in most gastroduodenal disorders of childhood can alter natural history and improve overall quality of life.
Related Concept Videos
Other Disorders of Digestive System
Peptic Ulcer
Gastroesophageal Reflux Disease
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...